Iron Prophylaxis for Anemia in Infants With Cyanotic Congenital Heart Disease

• Status: Withdrawn
• Trial end date: 2013-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Anemia is a common disorder in infants with one working chamber of the heart that pumps blood. Anemia is when the level of healthy blood cells becomes too low. This may cause other health problems because red blood cells contain hemoglobin, which carries oxygen (needed for survival) to different parts of the body.

This study will look at the role of iron in preventing anemia in infants with one pumping chamber. The importance of iron therapy will be examined.

Hypothesis: Prophylactic use of iron in infants with single ventricle is effective in preventing anemia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Emory University
• Collaborator: Children's Healthcare of Atlanta
• Treatments: Iron

Criteria

Inclusion Criteria:

• Single ventricle physiology (hypoplastic left heart syndrome [HLHS], tricuspid atresia, double inlet left ventricle [DILV], some double outlet right ventricle [DORV], heterotaxy, etc.)

• Age less than or equal to 2 months

• Saturations less than or equal to 90%

• Tolerating enteral feeds

• Informed consent being obtained

Exclusion Criteria:

• Age > 2 months

• Saturations > 90%

• Total parenteral nutrition

• Chronic kidney disease

• Prior iron therapy

• Hemolytic anemia